Breast Cancer
Showing NaN - NaN of 237
Neutropenia, Breast Cancer Trial in Worldwide (SPI-2012, Pegfilgrastim, Docetaxel)
Advanced Solid Tumors, Solid Tumors, Ovarian Cancer Trial in Australia, United States (TALZENNA capsule, Talazoparib soft gel
Active, not recruiting
- Advanced Solid Tumors
- +7 more
- TALZENNA capsule
- Talazoparib soft gel capsule
-
Encinitas, California
- +31 more
Feb 14, 2022
Breast Cancer Trial in Los Angeles, Bronx (Gedatolisib, Faslodex, Palbociclib)
Active, not recruiting
- Breast Cancer
- Gedatolisib
- +3 more
-
Los Angeles, California
- +1 more
Jan 25, 2022
Mesothelioma, Bladder Cancer, Melanoma Trial in Australia, Canada, United States (MGD009)
Terminated
- Mesothelioma
- +12 more
- MGD009
-
Los Angeles, California
- +19 more
Feb 4, 2022
Advanced Cancer, Ovarian Cancer, Breast Cancer Trial in United States (COM701, COM701 with Opdivo (Nivolumab).)
Recruiting
- Advanced Cancer
- +9 more
- COM701
- COM701 with Opdivo (Nivolumab).
-
Los Angeles, California
- +10 more
Jan 25, 2022
Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan (DS-8201a), Capecitabine, Eribulin)
Active, not recruiting
- Breast Cancer
- Trastuzumab deruxtecan (DS-8201a)
- +5 more
-
Chandler, Arizona
- +207 more
Jan 25, 2022
Breast Cancer Trial in Worldwide (Abemaciclib, Standard Adjuvant Endocrine Therapy)
Active, not recruiting
- Breast Cancer
- Abemaciclib
- Standard Adjuvant Endocrine Therapy
-
Birmingham, Alabama
- +611 more
Jan 21, 2022
Breast Cancer Trial in Canada, Puerto Rico, United States (pegfilgrastim, AC regimen, cyclophosphamide)
Active, not recruiting
- Breast Cancer
- pegfilgrastim
- +4 more
-
Anniston, Alabama
- +541 more
Jan 19, 2022
Breast Cancer, Ovarian Cancer, Endometrial Cancer Trial in Korea, Republic of, United States (FPA150, Pembrolizumab)
Completed
- Breast Cancer
- +3 more
- FPA150
- Pembrolizumab
-
Scottsdale, Arizona
- +17 more
Jan 6, 2022
Breast Cancer, Lymphoma Trial in United States (Atorvastatin, Placebo)
Breast Cancer, Colorectal Cancer Trial in United States (Embedded primary care in cancer survivorship model)
Enrolling by invitation
- Breast Cancer
- Colorectal Cancer
- Embedded primary care in cancer survivorship model
-
Anaheim, California
- +12 more
Dec 17, 2021
Breast Cancer Trial in United States (Nivolumab, Ipilimumab, Nab-paclitaxel)
Active, not recruiting
- Breast Cancer
- Nivolumab
- +2 more
-
Los Angeles, California
- +7 more
Dec 2, 2021
Cancer, Cancer Metastatic, Tumors Trial in Los Angeles (Elly Mobile Phone Application)
Recruiting
- Cancer
- +22 more
- Elly Mobile Phone Application
-
Los Angeles, CaliforniaCedars Sinai Medical Center
Dec 7, 2021
Breast Cancer Trial in Worldwide (biological, drug, other)
Completed
- Breast Cancer
- ramucirumab (IMC-1121B)
- +2 more
-
Birmingham, Alabama
- +232 more
Nov 3, 2021
Breast Cancer Trial in United States (Eribulin Mesylate, Ixabepilone)
Breast Cancer, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Los Angeles, Newport Beach, Rochester
Recruiting
- Breast Cancer
- +2 more
- dietary intervention
- +2 more
-
Los Angeles, California
- +2 more
Nov 16, 2021
Breast Cancer Screening, Breast Carcinoma in Situ, Breast Cancer Trial in United States (Complete a health questionnaire,
Recruiting
- Breast Cancer Screening
- +2 more
- Complete a health questionnaire
- +3 more
-
Birmingham, Alabama
- +9 more
Nov 8, 2021
Breast Cancer Trial in Canada, Ireland, United States (Letrozole, Placebo)
Breast Cancer Trial in Los Angeles (Carbohydrate restricted dietary intervention, standard of care aromatase inhibitors)
Terminated
- Breast Cancer
- Carbohydrate restricted dietary intervention
- standard of care aromatase inhibitors
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Aug 27, 2021
Breast Cancer, Triple Negative Breast Cancer Trial in Los Angeles (Durvalumab, Radiation Therapy, Carboplatin)
Withdrawn
- Breast Cancer
- Triple Negative Breast Cancer
- Durvalumab
- +3 more
-
Los Angeles, CaliforniaCedars Sinai Medical Center
Aug 19, 2021
Breast Cancer Trial in United States (systemic chemo, axillary lymph node dissection, neoadjuvant therapy)
Active, not recruiting
- Breast Cancer
- systemic chemotherapy
- +5 more
-
Mobile, Alabama
- +323 more
Aug 16, 2021
Breast Cancer Trial in Worldwide (Tesetaxel and Capecitabine, Capecitabine)
Terminated
- Breast Cancer
- Tesetaxel and Capecitabine
- Capecitabine
-
Chandler, Arizona
- +206 more
Jul 26, 2021